Despite a significant increase among young women receiving the vaccine that protects against human papillomavirus, HPV vaccination rates remain low and interest in vaccination slightly decreased between 2008 and 2010 according to new findings from the American Journal of Public Health. Findings also showed varying responses to the vaccination between different sociodemographic groups.
Using data from the National Health Interview Survey, researchers investigated the latest trends in HPV vaccination uptake, interest in vaccination from unvaccinated women and reasons for not becoming vaccinated among unvaccinated women. Surveyed participants were women between the ages of 18 and 26.
Results indicated that vaccination uptake increased from 11.6 percent to 34.1 percent between 2008 and 2012. The top reasons for unvaccinated women to remain unvaccinated remained largely the same between 2008 and 2010, as respondents cited lack of need, lack of knowledge and safety concerns. Additional findings found that vaccination rates among Hispanic women or women with limited access to care were particularly low. This population was also more likely to be interested in receiving the vaccine.
“Educational efforts and vaccination initiatives should easily fit into the schedules of young women. This may be achieved by offering vaccinations and vaccine information in neighborhood pharmacies and college health clinics,” the study’s authors suggest.
Source: American Public Health Association
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.